CYDY — Cytodyn Cashflow Statement
0.000.00%
- $141.55m
- $170.32m
Annual cashflow statement for Cytodyn, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -56.2 | -124 | -155 | -211 | -79.8 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 6.12 | 55.2 | 55.4 | 137 | 35.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.19 | -1.59 | -20.1 | -4.78 | 19.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -50.5 | -68.8 | -118 | -77.7 | -25.1 |
Capital Expenditures | -0.045 | -0.041 | -0.122 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | — | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.045 | -0.041 | -0.122 | 0 | 0 |
Financing Cash Flow Items | -4.07 | -3.24 | 16.3 | 5.39 | 2.81 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 52.7 | 79.7 | 137 | 48 | 29.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.24 | 10.8 | 19.7 | -29.7 | 4.82 |